Fauci tells Congress: ‘There’s no guarantee that the vaccine is actually going to be effective’
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, addresses the coronavirus task force daily briefing at the White House in Washington, U.S., March 24, 2020.
DOD Awards $138 Million Contract, Enabling Prefilled Syringes for Future COVID-19 Vaccine
MAY 12, 2020
Statement attributed to Lt. Col. Mike Andrews, Department of Defense spokesman:
“Today the Department of Defense and the U.S. Department of Health and Human Services, announce a $138 million contract with ApiJect Systems America for “Project Jumpstart” and “RAPID USA,” which together will dramatically expand U.S. production capability for domestically manufactured, medical-grade injection devices starting by October 2020.
Spearheaded by the DOD’s Joint Acquisition Task Force (JATF), in coordination with the HHS Office of the Assistant Secretary for Preparedness and Response, the contract will support “Jumpstart” to create a U.S.-based, high-speed supply chain for prefilled syringes beginning later this year by using well-established Blow-Fill-Seal (BFS) aseptic plastics manufacturing technology, suitable for combatting COVID-19 when a safe and proven vaccine becomes available.
By immediately upgrading a sufficient number of existing domestic BFS facilities with installations of filling-line and technical improvements, “Jumpstart” will enable the manufacture of more than 100 million prefilled syringes for distribution across the United States by year-end 2020.
The contract also enables ApiJect Systems America to accelerate the launch of RAPID USA manufactured in new and permanent U.S.-based BFS facilities with the ultimate production goal of over 500 million prefilled syringes (doses) in 2021. This effort will be executed initially in Connecticut, South Carolina and Illinois, with potential expansion to other U.S.-based locations. RAPID will provide increased lifesaving capability against future national health emergencies that require population-scale vaccine administration on an urgent basis.
RAPID’s permanent fill-finish production capability will help significantly decrease the United States’ dependence on offshore supply chains and its reliance on older technologies with much longer production lead times. These supplies can be used if a successful SARS-COV-2 vaccine is oral or intranasal rather than injectable.”
The ApiJect syringes come with an optional RFID tag so that health care workers can track the GPS location and identity of the individual being injected. Via the Apiject.com website:
With an optional RFID/NFC tag on each BFS prefilled syringe, ApiJect will make this possible. Before giving an injection, the healthcare worker will be able to launch a free mobile app and “tap” the prefilled syringe on their phone, capturing the NFC tag’s unique serial number, GPS location and date/time. The app then uploads the data to a government-selected cloud database. Aggregated injection data provides health administrators an evolving real-time “injection map.”
This is coupled with “Operation Warp Speed” which skips many safety protocols and will deliver up to 500 million coronavirus vaccines.
The only reason 500 million vaccines would be needed is if they made them mandatory.
If you are worried about viruses which weaken over time, you should be petrified about a fast-tracked mandatory vaccine. Many of these vaccines include aborted fetal tissue cell-lines which have never been tested before. Even the FDA warns of potential risks to the vaccine recipient in two respects: oncogenicity and infectivity: https://madisonarealymesupportgroup.com/2020/04/09/gates-funded-coronavirus-vaccine-starts-testing-in-people/
How many Wisconsinites have an asymptomatic (no symptoms) case of Lyme? A vaccine could trigger symptoms held in check by the immune system. I’ve met with patients in this exact scenario.
Tell them that vaccines are created to evoke an immune response but Lyme patients already struggle with immune issues.
These are only the health concerns. There’s also the issue of Civil Rights.
Recently I posted about House Resolution 6666 and urged you to contact your representatives and senators: https://madisonarealymesupportgroup.com/2020/05/13/house-resolution-6666-traceact/ This resolution holds a large carrot out in terms of monies for grants ($100 Billion!), but padded in between the dollars is huge government overreach in that ‘contact tracing’ and monitoring are just fancy words for invasive surveillance. Kind of like a spoonful of sugar helps the medicine go down.
https://madisonarealymesupportgroup.com/2020/04/29/gates-patent-for-body-activity-data-apparatus/ This link talks about human-implantable ‘QUANTUM-DOT TATTOOS’ as a way to hold vaccination records as well as Patent #WO2020060606, which is described as a “Cryptocurrency System Using Body Activity Data,” that senses body activity of the user.The patent states that “conditions set by the cryptocurrency system” can be awarded cryptocurrency to the user. In other words, if you are a good boy or girl you get points.
And now we discover that the DOD has 500 million pre-filled vaccine syringes with an “optional RFID tag.”
This should scare you.
It should also be clear what the intent is. Bag and tag every citizen. Make sure they got their vaccine and know exactly where they are at all times.
Remind authorities that there has been wide-scale cover-up and lies about vaccines:
While presumed experts in Washington look for data that will justify reopening the economy, the third branch of government, the judiciary, has hardly been mentioned in the crisis to date but could play a key role in breaking any political stalemate. So my spirits soared when I saw a partial headline reading “Coronavirus: Battle Breaks Out As Beach Visits Allowed …” But then I clicked and saw the rest of the headline: “in Northern Germany.” (See link for article)
There’s plenty of collusion & fraud with COVID-19 as well.
Best quote:
Whatever the causes of this uncharacteristic bit of non-litigiousness, Americans should know that ample legal precedents suggest that most shelter in place orders are unlawful and unconstitutional.
Maine, Pennsylvania, Minnesota, Maryland, California, Colorado, North Carolina, Virginia and Kentucky followed suit. Protests were mostly organized on Facebook, which has announced that they are removing (censoring) anti-quarantine events promoted in California, Nebraska and New Jersey. https://abcnews.go.com/US/protests-coronavirus-stay-home-orders-spread-country/story?id=70242988
VALNEVA AND PFIZER ANNOUNCE COLLABORATION TO CO-DEVELOP AND COMMERCIALIZE LYME DISEASE VACCINE
MAY 11, 2020 —
As a follow-up to the previous petition update regarding “Direct Detection Tests for Lyme Disease”
Who’s got Lyme and who doesn’t ????
——— Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: tickbornedisease@hhs.gov
Cc: (98 Undisclosed recipients)
Date: May 7, 2020 at 8:27 AM
Subject: VALNEVA AND PFIZER ANNOUNCE COLLABORATION TO CO-DEVELOP AND COMMERCIALIZE LYME DISEASE VACCINE, VLA15
To the Tick-Borne Disease Working Group,
Please see the letter below sent to Valneva and Pfizer with copy to the principal investigator of VLA15.
Carl Tuttle
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: communications@valneva.com, Steven.Danehy@pfizer.com
Cc: par.comstedt@valneva.com, urban.lundberg@valneva.com, tickbornedisease@hhs.gov, sasheller@sheller.com
Date: May 7, 2020 at 8:19 AM
Subject: VALNEVA AND PFIZER ANNOUNCE COLLABORATION TO CO-DEVELOP AND COMMERCIALIZE LYME DISEASE VACCINE, VLA15
VALNEVA AND PFIZER ANNOUNCE COLLABORATION TO CO-DEVELOP AND COMMERCIALIZE LYME DISEASE VACCINE, VLA15
April 30, 2020
Phase 2 vaccine candidate, VLA15, is being evaluated for adult and pediatric indications in North America and Europe.
Have your clinical studies identified adverse reactions when VLA15 is administered to an individual with active Lyme disease? All Tuttle family members advanced to late stage Lyme disease before we knew what had gone wrong with our health and none of us met the CDC’s strict criteria for positive test results. The only FDA approved two-tier serology test is useless for 4-6 weeks after a tick bite because it takes that long for humans to develop antibodies against the spirochete responsible for Lyme disease.
So how do you plan to rule out active infection (before injection) if we don’t have an accurate and early direct detection test for Lyme disease? Our family’s experience is not unique as most Lyme patients who have become disabled by the infection went months, years or decades before diagnosis.
Until this scenario is recognized and fully addressed don’t expect overwhelming reception for a vaccine previously withdrawn with a record of a class action settlement for adverse reactions.
Respectfully Submitted,
Carl Tuttle
Lyme Endemic Hudson, NH
Cc:
Tick-Borne Disease Working Group
Sheller, P.C law firm Class Actions and Mass Torts
Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
The next time a tick feeds on you, Washington State University researchers hope to make sure persistent arthritis caused by Lyme disease doesn’t linger for a lifetime.
Troy Bankhead, associate professor in WSU’s Veterinary Microbiology and Pathology department, and his team have spent more than a decade analyzing an immune evasive protein of Borrelia burgdorferi, the bacterium that causes tick-borne Lyme disease.
With the lab’s latest finding, that work is beginning to pay off.
According to research recently published in Cell Reports, Bankhead and assistant research professor Abdul Lone discovered that a surface protein known as VlsE acts as a shield to prevent the immune system from effectively fighting the disease. In particular, the study examined how VlsE protects one of the main proteins responsible for Lyme disease’s persistent arthritis.
“This really has a significant impact in the development of vaccines,” Bankhead said. “If we can determine which proteins are shielded as opposed to which ones are not, then of course those that are not protected are going to be better candidates for a vaccine.”
The Centers for Disease Control and Prevention estimates some 300,000 people may get Lyme disease each year in the United States alone. It is most prevalent in the northeast.
If not treated early with antibiotics, Lyme disease can cause lifelong arthritis, and in more severe cases, bladder infections, heart inflammation, and neurologic and cognitive issues like loss of memory and balance.
“We chose the arthritis-related protein because arthritis is the most common symptom you see in North America,” Lone said.
By engineering a strain of Borrelia burgdorferi in the lab without the surface lipoprotein VlsE, they were able to confirm it was protecting the arthritis-related protein from an antibody response.
Bankhead and Lone tested the new Borrelia strain in mice and found the animals were more easily able to clear the infection.
Then, Bankhead and Lone confirmed that the new Borrelia strain was susceptible to antibodies under the microscope.
By using fluorescence microscopy, a process that uses energy from electrons to emit light under a microscope, Bankhead and Lone watched as antibodies were unable to bind to the protein responsible for Lyme’s persistent arthritis when the VlsE protein was present. When the VlsE protein was removed, antibodies were able to recognize and bind to the arthritis-related protein.
“When you don’t have VlsE those bacteria light up and that is because those antibodies are able to bind and recognize that arthritis-related protein in the absence of that VlsE shield,” Bankhead said. “That’s exactly what we were seeing.”
Understanding the VlsE protein is acting as a shield for the bacterium’s arthritic-causing protein is significant for vaccine development and future research. While it is unknown if other surface proteins are protected, Bankhead said it is likely. He noted the scientific community is gaining ground on understanding these proteins but producing any vaccine is well into the future.
Still, the finding creates two avenues for researchers to eliminate Lyme disease:
take down the VlsE shield, or,
find a way for the antibody response to get in front of the ever-adapting bacterium and eliminate it.
“HIV/AIDS persists for years in human beings. The same thing happens with Borrelia, it persists,” Lone said. “While this finding tells us a lot about Borrelia. Our next step is to understand how it persists. Once we understand the mechanism of persistence, we can eliminate the disease.”
Media contacts:
Troy Bankhead, WSU College of Veterinary Medicine, tbankhead@wsu.edu
Laura Lockard, WSU College of Veterinary Medicine, 206-861-6884, laura.lockard@wsu.edu
__________________
**Comment**
From where I sit, the saga of HIV/AIDS us far from conclusive. Similarly to the Cabal that myopically focused on amyloid,to the exclusion of all other potential causes, in regards to Alzheimer’s, there was a Cabal focusing solely on a “supposed” HIV virus that has yet to be truly (singularly) isolated with proof of an electron micrograph. This is also true of nearly every other virus being blamed for “pandemics” by authorities.
To date there are researchers who have held their ground that HIV does not cause AIDS – losing all in the process. I think we should take people like that seriously. They have everything to lose and nothing to gain by continuing to hold a stance that flies in the face of the narrative – similarly to Lyme doctors. Many have stood up in opposition to a virus causing AIDS: http://www.virusmyth.com/aids/group.htm
While 
Madison Area Lyme Support Group 